The Latest Breaking News from Omicron

Fainting and fatigue may signal onset of variant, experts say

The U.S. Food and Drug Administration (FDA) has approved Incyte’s (NASDAQ:INCY) Pemazyre (pemigatinib), a selective fibroblast growth factor receptor (FGFR) inhibitor, for the treatment of adults with relapsed or refractory myeloid/lymphoid neoplasms (MLNs) with FGFR1 rearrangement. Incyte shares traded in a range of $71.38 to $72.98 on day volume of 1.25…

‘Even having had Omicron, we’re not well protected from further infections,’ said Prof Danny Altmann

UK hit by fifth wave of infections earlier this summer driven by new Omicron variants

Fainting and fatigue may signal onset of variant, experts say

Queenslanders are no longer being asked to wear masks when indoors, as the third Omicron wave of COVID-19 continues to subside in the state.

Omicron’s mutations impaired vaccine effectiveness, CDC says

Anti-lockdown advocates have been claiming online this week that Victoria's Chief Health Officer Brett Sutton admitted that vaccines never worked. But that's not what he said.

Almost 40% of people hospitalized in the U.S. with the COVID-19 subvariant that circulated this spring were vaccinated and boosted, highlighting how new strains have mutated to more readily escape the immunity offered by current shots.